For post-menopausal women dealing with breast cancer, a new treatment option is now available.
Health Canada has now approved Femara or letrozole for the treatment of post-surgical early-stage hormone-dependent breast cancer.
The approval of Femara gives women more hope in their fight against breast cancer.
It's estimated that one in nine Canadian women will develop breast cancer during their lifetime.
Watch this video.